These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28060113)

  • 1. Adherence to Treatment, Response and Patterns of Failure in Pediatric Parameningeal Rhabdomyosarcoma: Experience From a Tertiary Cancer Care Center From India.
    Roy S; Pathy S; Mohanti BK; Chander S; Biswas A
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e62-e68. PubMed ID: 28060113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
    Chen C; Shu HK; Goldwein JW; Womer RB; Maity A
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1294-9. PubMed ID: 12654440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group.
    Casey DL; Chi YY; Donaldson SS; Hawkins DS; Tian J; Arndt CA; Rodeberg DA; Routh JC; Lautz TB; Gupta AA; Yock TI; Wolden SL
    Cancer; 2019 Sep; 125(18):3242-3248. PubMed ID: 31174239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL; Anderson J; Pappo AS; Meyer WH;
    J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head and neck rhabdomyosarcoma in children: a 20-year retrospective study at a tertiary referral center.
    Häußler SM; Stromberger C; Olze H; Seifert G; Knopke S; Böttcher A
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):371-379. PubMed ID: 29143871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma.
    Vaarwerk B; Hol MLF; Schoot RA; Breunis WB; de Win MML; Westerveld H; Fajardo RD; Saeed P; van den Brekel MW; Pieters BR; Strackee SD; Smeele LE; Merks JHM
    Radiother Oncol; 2019 Feb; 131():21-26. PubMed ID: 30773183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment.
    Liu YT; Wang CW; Hong RL; Kuo SH
    Anticancer Res; 2019 Mar; 39(3):1355-1364. PubMed ID: 30842169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation.
    Paulino AC; Bauman N; Simon JH; Nguyen TX; Ritchie JM; Tannous R
    Med Pediatr Oncol; 2003 Aug; 41(2):118-22. PubMed ID: 12825215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.
    Raney B; Anderson J; Breneman J; Donaldson SS; Huh W; Maurer H; Michalski J; Qualman S; Ullrich F; Wharam M; Meyer W;
    Pediatr Blood Cancer; 2008 Jul; 51(1):17-22. PubMed ID: 18266224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
    Abd El-Aal HH; Habib EE; Mishrif MM
    J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
    Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
    J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS
    Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parameningeal rhabdomyosarcoma: outcomes and opportunities.
    Yang JC; Wexler LH; Meyers PA; Wolden SL
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e61-6. PubMed ID: 23021437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study.
    Vaarwerk B; van der Lee JH; Breunis WB; Orbach D; Chisholm JC; Cozic N; Jenney M; van Rijn RR; McHugh K; Gallego S; Glosli H; Devalck C; Gaze MN; Kelsey A; Bergeron C; Stevens MCG; Oberlin O; Minard-Colin V; Merks JHM
    Cancer; 2018 Mar; 124(5):1016-1024. PubMed ID: 29211298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Intergroup Rhabdomyosarcoma Study-II.
    Maurer HM; Gehan EA; Beltangady M; Crist W; Dickman PS; Donaldson SS; Fryer C; Hammond D; Hays DM; Herrmann J
    Cancer; 1993 Mar; 71(5):1904-22. PubMed ID: 8448756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.
    Arndt CA; Stoner JA; Hawkins DS; Rodeberg DA; Hayes-Jordan AA; Paidas CN; Parham DM; Teot LA; Wharam MD; Breneman JC; Donaldson SS; Anderson JR; Meyer WH
    J Clin Oncol; 2009 Nov; 27(31):5182-8. PubMed ID: 19770373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive induction chemotherapy and delayed irradiation in the management of parameningeal rhabdomyosarcoma.
    Smith SC; Lindsley SK; Felgenhauer J; Hawkins DS; Douglas JG
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):774-9. PubMed ID: 14528099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of rhabdomyosarcoma at the National Cancer Center Hospital].
    Beppu Y; Fukuma H; Chuma H; Ise T; Ohira M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1603-13. PubMed ID: 3592704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult rhabdomyosarcoma in the nasal and paranasal sinuses showing complete local response to a combination of chemotherapy and radiotherapy using 3D-CRT and IMRT.
    Muto E; Shioyama Y; Nakamura K; Ohga' S; Nomoto S; Toba T; Yoshitake T; Soeda H; Terashima H; Honda H
    Fukuoka Igaku Zasshi; 2005 Oct; 96(10):363-9. PubMed ID: 16408493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.